ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q4Scopus Q3SCImago #9,299Hybrid

Growth Hormone & Igf Research

Acronym:ghir
•
Abbreviation (ISO):GROWTH HORM IGF RES
•
Identifier (ISSN):1096-6374(Print)/1532-2238(Online)
•
Publisher:Elsevier Ltd
Clarivate IF (2026)
2↑ +0.4
Journal Impact Factor
IF Trend↓
WoS Quartile
Q4
WoS SCIEJCR Quartile
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Growth Hormone & Igf Research

WoS Q4
01342.3720182.1720191.6220202.3720212.1320221.420231.620241.6202522026
Annual Impact Factor Metric
Current (2026):2
Scopus SJR & RankScopus Q3
0.633
#9,299

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
72

72 papers with at least that number of citations each

WoS: SCIE / JCRQ4
Self-Citation Rate0%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
33articles/year
20% Gold OA•89.47% Original Research

Aims & Scope

Growth Hormone & IGF Research is a forum for research on the regulation of growth and metabolism in humans, animals, tissues and cells. It publishes articles on all aspects of growth-promoting and growth-inhibiting hormones and factors, with particular emphasis on insulin-like growth factors (IGFs) and growth hormone. This reflects the increasing importance of growth hormone and IGFs in clinical medicine and in the treatment of diseases.

Topics Covered (Recognized by AI)
Medicine89.6%Biology89%Internal medicine86%Chemistry78.4%Endocrinology76.5%Biochemistry75.5%Genetics58.2%Hormone44.7%Growth hormone37.7%Pathology30.1%Receptor29.6%Gene23.1%

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSCIE2026

CELL BIOLOGY

Q4
Rank172/207
IndexSCIE
JCRSCIE2026

ENDOCRINOLOGY & METABOLISM

Q4
Rank152/198
IndexSCIE
JCISCIE2026

CELL BIOLOGY

Q4
Rank185/207
IndexSCIE
JCISCIE2026

ENDOCRINOLOGY & METABOLISM

Q4
Rank164/198
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF2
Articles / Year28
Total Citations5
2025
IF1.6
Articles / Year20
Total Citations11
2024
IF1.6
Articles / Year24
Total Citations61
2023
IF1.4
Articles / Year20
Total Citations103
2022
IF2.125
Articles / Year40
Total Citations259

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #9,299Scopus Q3SCImago Profile
Scopus Coverage:1998-2026
Scopus Broad Areas:Biochemistry, Genetics and Molecular BiologyMedicine
Scopus Citation Rank (SJR)Q3
0.633

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q3
Citations / Doc (2 years)
2.36

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$2,937 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations159
3-Year Documents72
Citable Documents72

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate47.4%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

EndocrinologyQ3
Endocrinology, Diabetes and MetabolismQ3
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 0%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
4区 (Zone 4)Medicine
Minor Category (Specific Field):
4区CELL BIOLOGY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Growth Hormone & Igf Research (acronym: ghir, abbr: GROWTH HORM IGF RES, ISSN: 1096-6374) is a peer-reviewed international scholarly journal in the field of Medicine, published by Elsevier Ltd in England. The periodical holds a Journal Impact Factor (JIF) of 2.00, ranking in quartile Q4 of Web of Science (SCIE), a Scopus SJR indicator of 0.633 (Q3), an H-index of 72.

The journal enforces rigorous peer evaluation with a publication frequency of Bimonthly, an annual output of approximately 33 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $2,937 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
Elsevier Ltd
Publication Language
English
Frequency
Bimonthly
Indexing & Databases
SCIEScopusPubMed
Editorial Address
CHURCHILL LIVINGSTONE, JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH, SCOTLAND, MIDLOTHIAN, EH1 3AF

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: 5e7ee29f-7981-4fb4-8c63-9e52744809c9
Database Updated: 2026-10-16